BlossomHill Therapeutics administers treatment to patients in initial stage of SOLARA trial for BH-30643 in non-small cell lung cancer with EGFR and HER2 mutations.

More Info:$XBI $IBB $XPH $PPH
#XBI #IBB #XPH #PPH